BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7438126)

  • 21. EORTC phase II trial of vindesine in advanced melanoma.
    Rümke P; Everall JD; Mulder JH; Rozencweig M; Czarnetzki B; Thomas D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1173-4. PubMed ID: 6684562
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
    Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
    Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
    Wong PP; Yagoda A; Currie VE; Young CW
    Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vindesine: a new antineoplastic drug].
    Baccarani M; Corbelli G
    G Clin Med; 1981 Feb; 62(2):129-34. PubMed ID: 7016650
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trial of vindesine in advanced gastric cancer.
    Kenny JB; Scarffe JH; Maley WV
    Cancer Treat Rep; 1983 Jan; 67(1):89-90. PubMed ID: 6311414
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of combination chemotherapy using vindesine or vincristine with adriamycin in the treatment of advanced breast carcinoma.
    Smith IE; Hedley DW; Coombes RC; Powles TJ
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():71-3. PubMed ID: 7438125
    [No Abstract]   [Full Text] [Related]  

  • 31. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
    Diaz-Rubio E; Martin-Jimenez M
    Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
    [No Abstract]   [Full Text] [Related]  

  • 33. Update results of vindesine as a single agent in the therapy of advanced malignant melanoma.
    Retsas S; Peat I; Ashford R; Coe M; Maher J; Drury A; Hanham IW; Phillips RH; Newton KA; Westbury G
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():87-90. PubMed ID: 7438128
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II study of vindesine in patients with Hodgkin's disease, lymphoma, and breast cancer.
    Gad-El-Mawla N; Hamza MR; El-Serafi M; El-Khoudary A; Aboul-Einein M; El-Demerdash S
    Cancer Treat Rep; 1983 Mar; 67(3):316-7. PubMed ID: 6831481
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of vindesine in adenocarcinoma of the lung.
    Sledge GW; Clark GM; Von Hoff DD
    Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
    [No Abstract]   [Full Text] [Related]  

  • 36. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
    Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
    Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.
    Mattson K; Holsti LR; Salmo M; Saastamoinen M; Ahlstedt S; Holsti P
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():65-70. PubMed ID: 7438124
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.